Literature DB >> 21472868

Sequential development of diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma.

Jing Huang1, Pei-Hong Zhang, Yu-Huan Gao, Lu-Gui Qiu.   

Abstract

Lymphoma of different histologic type can occur in the same patient. Here, we describe a 64-year-old male patient with angioimmunoblastic T-cell lymphoma (AITL) who subsequently developed diffuse large B-cell lymphoma (DLBCL). At the time of initial diagnosis, histologic examination of a left inguinal lymph node of the patient and a monoclonal pattern of TCRβ gene rearrangement showed typical features of AITL, and there was no evidence of a monoclonal B-cell population. Twenty-six months later, he had generalized lymphadenopathy and organs involvement by DLBCL. A monoclonal IgH gene rearrangement proved de novo development of secondary B-cell lymphoma and excluded relapse of a primary composite lymphoma. The in situ hybridization analysis showed Epstein-Barr-encoded RNA (EBER) sporadic positivity in sample collected from AITL but extensive positivity in the immunoblasts collected from DLBCL. Our observation supports the hypothesis that Epstein-Barr virus (EBV) is etiologically related to AITL in this case. Clonal expansion of EBV-associated DLBCL is a secondary event in AITL via EBV infection or reactivation.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21472868     DOI: 10.1002/dc.21641

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  12 in total

Review 1.  Development of angioimmunoblastic T-cell lymphoma after treatment of diffuse large B-cell lymphoma: a case report and review of literature.

Authors:  Yaya Wang; Bailu Xie; Yu Chen; Zhenqian Huang; Huo Tan
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

2.  A Case of Cutaneous Epstein-Barr Virus-Associated Diffuse Large B-Cell Lymphoma in an Angioimmunoblastic T-Cell Lymphoma.

Authors:  Mi-Hye Lee; Ik-Jun Moon; Woo-Jin Lee; Chong-Hyun Won; Sung-Eun Chang; Jee-Ho Choi; Mi-Woo Lee
Journal:  Ann Dermatol       Date:  2016-11-23       Impact factor: 1.444

3.  Cerebellar EBV-associated diffuse large B cell lymphoma following angioimmunoblastic T cell lymphoma.

Authors:  Yi Zhou; Marc K Rosenblum; Ahmet Dogan; Achim A Jungbluth; April Chiu
Journal:  J Hematop       Date:  2015-03-18       Impact factor: 0.196

Review 4.  Neoplasms of follicular helper T-cells: an insight into the pathobiology.

Authors:  Surabhi Jain; Saumyaranjan Mallick; Prashant Ramteke; Ajay Gogia
Journal:  Am J Blood Res       Date:  2022-06-20

5.  EBV Negative Angioimmunoblastic T-Cell Lymphoma with Sequential Development of Diffuse Large B-Cell Lymphoma in Course of Progression.

Authors:  Ivan Petković; Slavica Stojnev; Aleksandar Popović; Miljan Krstić; Ivica Pejčić
Journal:  Indian J Hematol Blood Transfus       Date:  2021-03-25       Impact factor: 0.915

Review 6.  Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature.

Authors:  Qing-Xu Yang; Xiao-Juan Pei; Xiao-Ying Tian; Yang Li; Zhi Li
Journal:  Diagn Pathol       Date:  2012-01-19       Impact factor: 2.644

7.  The Prognostic Role of Circulating Epstein-Barr Virus DNA Copy Number in Angioimmunoblastic T-Cell Lymphoma Treated with Dose-Adjusted EPOCH.

Authors:  Jin-Hua Liang; Luo Lu; Hua-Yuan Zhu; Wang Li; Lei Fan; Jian-Yong Li; Wei Xu
Journal:  Cancer Res Treat       Date:  2018-04-02       Impact factor: 4.679

8.  Angioimmunoblastic T-Cell Lymphoma Presenting with an Acute Serologic Epstein-Barr Virus Profile.

Authors:  Timothy Beer; Patrick Dorion
Journal:  Hematol Rep       Date:  2015-06-03

9.  Two cases of angioimmunoblastic T-cell lymphoma with concomitant positive serology for acute Epstein-Barr virus infection.

Authors:  Davide Facchinelli; Angela Polino; Francesco Dima; Alice Parisi; Achille Ambrosetti; Dino Veneri
Journal:  Hematol Rep       Date:  2017-09-27

Review 10.  New preclinical models for angioimmunoblastic T-cell lymphoma: filling the GAP.

Authors:  Rana Mhaidly; Adrien Krug; Philippe Gaulard; François Lemonnier; Jean-Ehrland Ricci; Els Verhoeyen
Journal:  Oncogenesis       Date:  2020-08-14       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.